Clinical Trial Update: A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function [Phase 1]

View source ↗

Summary

ClinicalTrials.gov reports a Phase 1 study of Eloralintide (LY3841136) in participants with renal impairment and those with normal renal function, focusing on s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Eloralintide (LY3841136)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Kidney Disease, Renal Insufficiency Chronic | Phase 1 | Status: RECRUITING